Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients

被引：0
|
作者：
Cargnel, A
Angeli, E
Mainini, A
Gubertini, G
Giorgi, R
Orlando, G
Duca, P
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83871-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：A766 / A766
页数：1
相关论文
共 50 条
  • [31] Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin
    De Novelli, Fernando Jose
    Przysiezny, Andre
    Rosa, Evandro Luis
    Liermann Garcia, Raquel Francine
    Nobrega, Mario Junqueira
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2014, 77 (03) : 178 - 181
  • [32] A Case of Severe Thrombocytopenia in a Patient with Chronic Hepatitis C Caused by a Single Administration of Pegylated Interferon Alpha 2a Subsequent to 48 Weeks of Pegylated Interferon Alpha 2b Plus Ribavirin Therapy
    Kato, Hideaki
    Fujishiro, Takuya
    Narita, Makoto
    INTERNAL MEDICINE, 2010, 49 (16) : 1741 - 1744
  • [33] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON ALPHA (PEG-IFN alpha) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE 1
    Antonov, Krasimir
    Jelev, Deian
    Ivanova, A.
    Krastev, Zahariy
    JOURNAL OF IMAB, 2011, 17 (01): : 197 - 199
  • [34] Catatonia Associated with Pegylated Interferon-α 2b and Ribavirin for Hepatitis C
    Quinn, Davin
    Kuchler, Elizabeth
    Deming, Paulina
    Arora, Sanjeev
    PSYCHOSOMATICS, 2012, 53 (04) : 400 - 401
  • [35] Randomized Trial Comparing Pegylated Interferon α-2b Versus Pegylated Interferon α-2a, Both Plus Ribavirin, to Treat Chronic Hepatitis C in Human Immunodeficiency Virus Patients
    Laguno, Montserrat
    Cifuentes, Carmen
    Murillas, Javier
    Veloso, Sergio
    Larrousse, Maria
    Payeras, Antoni
    Bonet, Lucia
    Vidal, Francesc
    Milinkovic, Ana
    Bassa, Antoni
    Villalonga, Concha
    Perez, Inaki
    Tural, Cristina
    Martinez-Rebollar, Maria
    Calvo, Marta
    Luis Blanco, Jose
    Martinez, Estaban
    Sanchez-Tapias, Jose M.
    Gatell, Jose M.
    Mallolas, Jose
    HEPATOLOGY, 2009, 49 (01) : 22 - 31
  • [36] IMPACT OF PEGYLATED INTERFERON α2B PLUS RIBAVIRIN TREATMENT FOR CHRONIC HEPATITIS C PATIENTS WITH HISTORY OF HEPATOCELLULAR CARCINOMA
    Ogawa, E.
    Furusyo, N.
    Kajiwara, E.
    Takahashi, K.
    Nomura, H.
    Tanabe, Y.
    Satoh, T.
    Maruyama, T.
    Nakamuta, M.
    Kotoh, K.
    Azuma, K.
    Dohmen, K.
    Shimoda, S.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S452 - S452
  • [37] Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
    Pérez-Olmeda, M
    Núñez, M
    Romero, M
    González, J
    Castro, A
    Arribas, JR
    Pedreira, J
    Barreiro, P
    García-Samaniego, J
    Martín-Carbonero, L
    Jiménez-Nácher, I
    Soriano, V
    AIDS, 2003, 17 (07) : 1023 - 1028
  • [38] Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
    Callens, S
    Bottieau, E
    Michielsen, P
    Colebunders, R
    AIDS, 2004, 18 (01) : 131 - 131
  • [39] Efficacy and safety of pegylated interferon-α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Santin, M
    Shaw, E
    Garcia, MJ
    Delejido, A
    De Castro, ER
    Rota, R
    Altés, J
    Baguena, F
    Valero, S
    Sala, M
    Casanova, A
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (04) : 315 - 320
  • [40] Pegylated interferon α-2b plus ribavirin in the re-treatment of patients non responsive to IFN/ribavirin
    Taliani, G
    Aceti, A
    Capanni, M
    Esperti, E
    Ferrari, C
    Forte, P
    Framarin, L
    Guadagnino, V
    Leoncini, E
    Luchi, S
    Marino, N
    Mazzotta, E
    Milani, S
    Pasquazzi, C
    Rosina, E
    Tacconi, D
    Stroffolini, T
    Zignego, AL
    JOURNAL OF HEPATOLOGY, 2005, 42 : 222 - 222
12345